20 annual accounts with figures on one time axis, 30 filings since 1996
peak of €267,216 in 2016
€247,744▲ 21.7%
peak of €115,474 in 2025
€115,474▲ 53.7%
peak of €950,588 in 2016
€869,111▼ 3.4%
€52,744▲ 16.3%
peak of 2.1 FTE in 2006
0.7 FTE▲ 40.0%
Board4 names since 1996
4 directorsName after signing inVisible after signing in and 3 others
Documentsfilings and deeds
08-06-202653 days before the deadline
2025abbreviated format
Gross margin from €203,547 to €247,744Result from €75,116 to €115,474Staff from 0.5 FTE to 0.7 FTEDividend €146,115Debts from €45,333 to €52,744Cash from €208,315 to €333,678
Higher solvency than 95% of companies in retail trade. The sector median is 36.8%, over 13,303 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 31,390 companies had the same profile as MEDIFAR has now. Each dot stands for 79 companies, two years later.
93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
Micro
20 years or older
solvency 30% or more
a profit of 5% of the balance sheet or more
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,390 companies, not a prediction for MEDIFAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0456978480
1 director appointed, 2 reappointmentsName hiddenVisible after signing in (director and managing director) and Hidden nameVisible after signing in (director) reappointed · Name after signing inVisible after signing in appointed as director · Name hiddenVisible after signing in and Hidden nameVisible after signing in act as permanent representatives · General meeting of 23-05-2024 · Gazette deed
Name after signing inVisible after signing in appointed as directorName hiddenVisible after signing in acts as permanent representative · General meeting of 26-06-2018 · Gazette deed
Capital decrease of €589,500 to €62,000
The capital fell from €651,500 to €62,000 · General meeting of 27-12-2017 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as MEDIFAR: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €870,000 and €1m, founded between 1987 and 2000.
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of MEDIFAR?
MEDIFAR is a public limited company (NV).
When was MEDIFAR founded?
MEDIFAR was founded on 03-01-1996.
Is MEDIFAR still active?
Yes, MEDIFAR is an active enterprise in the KBO register.
How many employees does MEDIFAR have?
MEDIFAR had an average of 0.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does MEDIFAR fall under?
In its 2021 annual accounts, MEDIFAR states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of MEDIFAR?
The turnover in financial year 2025 is about €1.2m. This figure is estimated from the gross margin of €247,744 and 43 comparable companies (NACE 477). It probably lies between €760,000 and €2.4m.
Is MEDIFAR profitable?
In financial year 2025, MEDIFAR made a profit of €115,474.
Where can I find the annual accounts of MEDIFAR?
MEDIFAR filed 30 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MEDIFAR due?
MEDIFAR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline